New Survey: Consumers Want Tested Cannabis with Transparent Labeling and Do Not Assume Legal Products Are Necessarily Safe

Three-quarters of Americans say labels impact purchasing decisions, while almost half demand tested and treated cannabis

0 %

of consumers said clear labeling around how cannabis is treated would impact their purchasing decisions.

0 %

associate cannabis decontamination with removing harmful contaminants, and 47.2% associate the term with safety and quality control.

0 %

associated decontamination with chemicals, and 10% associated it with radiation.

The assumptions are over. XRpure’s national 2026 consumer survey proves transparency about decontamination builds loyalty, strengthens trust, and positions cannabis brands for success.

This report details how consumers view decontamination, how expectations differ between medical and adult-use consumers, and how transparency is becoming a key driver of purchasing decisions.

If you work in cultivation, QA, or brand management, this data offers a strategic advantage.

Worker using XRpure XR16: X-ray Cannabis Decontamination Digital interface

Download the 2026 Consumer Survey

Who This Is For

Cultivation leaders, QA teams, brand managers, and executives who need reliable data on consumer perceptions around decontamination and product safety.

Cannabis Cultivator writing findings down on notepad about cannabis plants in grow house

What’s Inside

Use the data. Earn the trust.